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The genetic basis of odorant-specific variations in human olfactory thresholds, and in particular of enhanced odorant
sensitivity (hyperosmia), remains largely unknown. Olfactory receptor (OR) segregating pseudogenes, displaying both
functional and nonfunctional alleles in humans, are excellent candidates to underlie these differences in olfactory
sensitivity. To explore this hypothesis, we examined the association between olfactory detection threshold phenotypes
of four odorants and segregating pseudogene genotypes of 43 ORs genome-wide. A strong association signal was
observed between the single nucleotide polymorphism variants in OR11H7P and sensitivity to the odorant isovaleric
acid. This association was largely due to the low frequency of homozygous pseudogenized genotype in individuals
with specific hyperosmia to this odorant, implying a possible functional role of OR11H7P in isovaleric acid detection.
This predicted receptor–ligand functional relationship was further verified using the Xenopus oocyte expression
system, whereby the intact allele of OR11H7P exhibited a response to isovaleric acid. Notably, we also uncovered
another mechanism affecting general olfactory acuity that manifested as a significant inter-odorant threshold
concordance, resulting in an overrepresentation of individuals who were hyperosmic to several odorants. An
involvement of polymorphisms in other downstream transduction genes is one possible explanation for this
observation. Thus, human hyperosmia to isovaleric acid is a complex trait, contributed to by both receptor and other
mechanisms in the olfactory signaling pathway.
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journal.pbio.0050284
Introduction
Humans are highly variable in their olfactory perception.
Such phenotypic diversity has been known for nearly a
century, indicating a widespread occurrence of odorant-
speciﬁc sensitivity variations [1–6] as well as of differences in
general olfactory acuity [1–3]. These variations in chemo-
sensory sensitivity often span several orders of magnitude
[1,4–8], with extreme manifestation in speciﬁc anosmia or
‘‘smell blindness’’ [9–11]. Such human olfactory traits have
been suggested to constitute a complex trait, affected by both
environmental and genetic factors [6,8,11–13]. While speciﬁc
anosmia and its milder representation, speciﬁc hyposmia,
have been extensively studied, less attention has been devoted
to the study of the other extreme of the olfactory threshold
spectrum, hyperosmia [14,15].
Considerable evidence points to a signiﬁcant genetic
contribution to olfactory threshold variation. For example,
a higher concordance of olfactory thresholds towards
androstenone was found in monozygotic twins than in
dizygotic twins [13,16]. Moreover, a family-based study with
pentadecalactone and isovaleric acid (IVA) [11] suggested that
for some odorants anosmia constitutes a recessive Mendelian
trait. Corroborating evidence was reported in particular
mouse strains [17], in which odor-speciﬁc threshold differ-
ences to IVA were shown to be recessively inherited [18,19]. A
subsequent linkage analysis of this phenotype found associ-
ation with two distinct genomic loci, on mouse Chromosomes
4 and 6 [18]. Nevertheless, the genes underlying this sensory
trait remain unknown. In the nematode Caenorhabditis elegans,
on the other hand, mutations in a deﬁned odorant receptor
gene (odr-10) were shown to be responsible for speciﬁc
response deﬁcits to the odorant diacetyl [20].
Olfactory receptors (ORs) mediate the ﬁrst step in odorant
recognition [21], and their polymorphisms likely constitute
the molecular basis for odorant-speciﬁc threshold variations.
Of the 856 OR genes and pseudogenes dispersed throughout
the entire human genome [22,23], a subclass of more than 60
OR loci appear particularly relevant, as they harbor damag-
ing single nucleotide polymorphisms (SNPs) in their coding
regions, leading them to segregate between an intact and a
disrupted (pseudogenized) allele in the human population
[24,25]. Each of these segregating pseudogenes (SPGs) is a
natural knockout with a potential to underlie sensitivity
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PLoS BIOLOGYvariations towards certain chemosensory ligands. As a group,
SPG loci harbor a remarkable combinatorial genetic diversity
[24], perhaps one of the largest in the human genome [26].
To explore the possible involvement of OR SPGs in human
olfactory threshold variation, we launched a genotype–
phenotype association study of the underlying SNPs of 43
OR segregating loci and olfactory threshold measurements
for four odorants in 377 individuals. We found a statistically
signiﬁcant association between the presence of a nonsense
SNP within the coding region of the OR OR11H7P and
detection threshold differences for the sweaty odorant IVA,
suggesting a locus related to speciﬁc hyperosmia. This
predicted OR–ligand relationship was validated by an in
vitro expression assay [27]. Furthermore, we observed a
signiﬁcant concordance between odorant thresholds within
individuals, likely governed by another inherent mechanism
affecting general olfactory sensitivity. Our results suggest that
the extensive olfactory threshold variation among humans is
a complex trait, contributed to both by OR-speciﬁc variations
and by potential inter-individual differences in downstream
components in the olfactory signaling pathway.
Results
Human Olfactory Threshold Variation
To study the possible genetic mechanism of human
olfactory threshold variation, we measured detection thresh-
olds of four odorants—isoamyl acetate (IAA), isovaleric acid
(IVA), L-carvone (LCA), and cineole (CIN)—in 377 individu-
als. In accordance with previous observations [10], a broad
Gaussian distribution was seen for all odorants, spanning the
entire concentration range (10
 2–10
 6 M; Figure 1). The
reproducibility of our threshold determination was indicated
by a test–retest correlation (R ¼ 0.73 6 0.03, average of four
odorants) in 82 randomly selected participants (Figure S1).
Examination of other potential confounding factors revealed
a noticeable difference between the thresholds of the two
genders, with females exhibiting higher sensitivities towards
all odorants (Table S1). In contrast, age, smoking habits, and
ethnic origin did not show an effect.
Genotype–Phenotype Association
To test the possible involvement of OR SPGs in the
observed odorant-speciﬁc olfactory threshold differences, we
genotyped the underlying disrupting SNPs of 52 candidate
OR SPGs (Table S2) in 377 individuals for whom genomic
DNA was available. Of these, the genotypes of nine SNPs did
not meet our quality assurance requirements (see Materials
and Methods) and thus were removed from further scrutiny.
The genotypes of the remaining 43 SNPs were further used
for our genotype–phenotype analysis. Based on previous
studies [11,13,18,19], we assumed Mendelian recessive inher-
itance of speciﬁc hyposmia, thus grouping together homo-
zygous intact and heterozygous individuals. Comparison of
the olfactory thresholds for individuals carrying different OR
genotypes revealed a strong association signal between the
genotyped SNP in OR11H7P and sensitivity to the odorant
IVA (F ¼18.4, p ¼ 2.29 3 10
 5) (Figure 2). This association is
explicitly revealed in the IVA threshold distribution (Figure
1B), in which participants homozygous for the disrupted
allele (the pseudogene) are signiﬁcantly depleted in the two
highest olfactory sensitivity bins. That is, individuals with
speciﬁc hyperosmia to IVA are more likely to be heterozygous
or homozygous intact, than homozygous disrupted. This
observation is consistent with the notion that individuals
bearing no functional copy of OR11H7P would be incapable
of detecting IVA at low concentrations. Interestingly, another
SNP with an association signal with IVA detection (though
not statistically signiﬁcant at the a ¼ 0.05 level) is in the
OR4Q2P gene, which is situated ;225 kb downstream of the
OR11H7P gene and within the same OR genomic cluster, 14@
Figure 1. Olfactory Threshold Distributions
Histograms of the measured olfactory thresholds for four odorants: IAA
(A), IVA (B), LCA (C), and CIN (D). Odorants are expressed in molar (M)
concentrations (in the oil solution) and were tested in 377 genotyped
individuals, except CIN, which was tested in a randomly selected
subsample of 200 participants. The data are presented for both genders
pooled together. A threshold score of one indicates individuals who
could not detect the highest possible odorant concentration (10
 2 M).
Red, yellow, and green, respectively, represent fractions out of the total
sample for homozygote disrupted, heterozygote, and homozygote intact
OR11H7P genotypes.
doi:10.1371/journal.pbio.0050284.g001
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Author Summary
Humans can accurately discern thousands of odors, yet there is
considerable inter-individual variation in the ability to detect
different odors, with individuals exhibiting low sensitivity (hypo-
smia), high sensitivity (hyperosmia), or even ‘‘blindness’’ (anosmia)
to particular odors. Such differences are thought to stem from
genetic differences in olfactory receptor (OR) genes, which encode
proteins that initiate olfactory signaling. OR segregating pseudo-
genes, which have both functional and inactive alleles in the
population, are excellent candidates for producing this olfactory
phenotype diversity. Here, we provide evidence that a particular
segregating OR gene is related to sensitivity to a sweaty odorant,
isovaleric acid. We show that hypersensitivity towards this odorant is
seen predominantly in individuals who carry at least one copy of the
intact allele. Furthermore, we demonstrate that this hyperosmia is a
complex trait, being driven by additional factors affecting general
olfactory acuity. Our results highlight a functional role of segregat-
ing pseudogenes in human olfactory variability, and constitute a
step towards deciphering the genetic basis of human olfactory
variability.19.5 (http://bioportal.weizmann.ac.il/HORDE) (Figure 3). The
weak mutual linkage disequilibrium (r
2 ¼ 0.13, p , 0.01)
between these two polymorphic loci may contribute to the
elevated association signal in the OR4Q2P gene as exempliﬁed
by the inferior statistical signiﬁcance when both SNPs are
ﬁtted in the same analysis (Figure 2).
In Vitro Functional Expression
Our genotype–phenotype analysis implies a functional
relation between OR11H7P and the odorant IVA. To test
this possibility, we coexpressed the intact allele of OR11H7P
(OR11H7Pi) with human GNAL (guanine nucleotide binding
protein [G protein], alpha activating activity polypeptide, olfactory
type) and human CFTR (cystic ﬁbrosis transmembrane conductance
regulator [ATP-binding cassette sub-family C, member 7]) in Xenopus
(frog) oocytes, and tested against various concentrations of
IVA (from 30 lM to 10 mM; data not shown). OR11H7Pi
responded to 3 mM IVA (Figure 4). In contrast, the
uncorrected (pseudogenized) OR11H7P and three other
randomly chosen intact human ORs (OR52E4, OR8A1, and
OR12D2) did not yield speciﬁc responses to 3 mM IVA (Figure
4). Furthermore, we tested oocytes expressing an unrelated
receptor (the rat a4b2 neuronal nicotinic receptor) and
observed no responses to 3 mM IVA or to 1 mM 3-isobutyl-1-
methylxanthine (IBMX) (data not shown). These results
demonstrate that the response of OR11H7Pi to IVA is
receptor speciﬁc. We also expressed and tested OR11H4
and OR11H6, the two receptor genes that ﬂank OR11H7P
within the same linkage disequilibrium block (Figure 3).
Similar to OR11H7Pi, both of these receptors responded to 3
mM IVA (Figure 4), but not to lower concentrations of IVA
(data not shown). Notably, the average response signal of
OR11H7Pi was higher than those of OR11H4 and OR11H6
Figure 2. Genotype–Phenotype Association
ANOVA p-values for comparison between the olfactory threshold
distributions of participants with homozygous disrupted genotypes
versus heterozygous and homozygous intact genotypes (1 df), using
‘‘gender’’ and ‘‘gender by genotype’’ as covariates. SPG loci are
enumerated as in Table S2. The broken line indicates the statistically
significant value of p¼0.05 after Bonferroni correction for 172 tests (four
odorants343 SPGs). The two strongest p-values for IVA are for the genes
marked in Figure 3. Using the individual’s average threshold towards the
four odorants as an additional covariate did not change the association
signal with OR11H7P (open circle in IVA panel). The association signal
with OR4Q2P is reduced after adjusting for the OR11H7P effect (solid
square in IVA panel).
doi:10.1371/journal.pbio.0050284.g002
Figure 3. The Genomic Region Associated with IVA Hyperosmia
OR genes are represented by red, green, and yellow triangles indicating pseudogenes, intact genes, and SPGs, respectively. The two SPGs showing the
strongest association with IVA sensitivity are marked with single and double asterisks. A linkage disequilibrium plot of SNPs with minor allele frequency
  5% in HapMap CEU [46] is depicted for this genomic region. The pairwise r
2 values are indicated on a gray scale, with black¼1 and white¼0. This
region contains also the putative OR-specific trans-acting enhancer element (H) [47,48].
doi:10.1371/journal.pbio.0050284.g003
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Genetic Elucidation of Human-Specific Hyperosmia(Figure 4B); however, these differences were not statistically
signiﬁcant. The three receptors that were activated by IVA
did not respond to similar concentrations of IAA, LCA, or
CIN (data not shown).
Inter-Odorant Threshold Correlation
A linear regression model reveals that the OR11H7P
polymorphism explains ;8% (r
2¼0.08) of the IVA threshold
variation in our data. Another ;50% of this variation is
attributed to intra-individual variance in our olfactory
threshold measurements (Figure S1). Thus, ;40% of the
variation in human IVA sensitivity remains unexplained. We
hypothesized that other mechanisms affecting the general
olfactory sensitivity might contribute to the threshold
variation towards IVA as well as to all other odorants. If
true, this would be revealed as inter-odorant threshold
concordances within individuals. Indeed, testing for such
inter-odorant threshold correlations revealed statistically
signiﬁcant results (p , 0.01) for all odorant pairs (Figure
S2). Notably, repeating the genotype–phenotype association
analysis using the average olfactory threshold score as an
additional covariate did not weaken the statistical signiﬁ-
cance of our results (see Figure 2). The effect of this general
olfactory sensitivity is further demarcated by the observation
that the average threshold distribution is signiﬁcantly broad-
er than the permuted one (F ¼ 1.83, p ¼ 1.68 3 10
 10; Figure
5A). Interestingly, the difference between the original and
permuted values was considerably larger in the lower values
of the average thresholds, implying that general hyperosmia is
more prevalent than general hyposmia in our sample. This is
also evident in Figure 5B, which displays the variety of
sensitivity phenotype combinations present. These observa-
tions imply that human sensitivity to IVA is determined by
multiple factors that may have an odorant-speciﬁc or general
olfactory effect.
Discussion
The results presented here provide a link between genetic
polymorphism in OR genes and phenotypic variation in
human olfaction. Such genetic underpinning for the highly
prevalent odorant-speciﬁc olfactory threshold differences in
the human population has been previously suggested [9,28],
but despite multiple reports of a genetic basis for these
human phenotypes [11,13,16], the underlying genes remained
unknown. Such a genotype–phenotype relationship has been
found in the nematode C. elegans, in which an OR gene (odr-10)
was shown to be necessary for speciﬁc responses to the
odorant diacetyl [20]. This result implies that OR gene
knockouts may underlie odor-speciﬁc threshold differences.
Human olfactory SPGs in fact constitute natural knockout
alleles, and the ﬁndings of the present study imply that they
might underlie some of the phenotypic variation in human
olfaction.
The genetic association between OR11H7P and IVA
detection is further supported by in vitro functional analyses
of this receptor that suggest a speciﬁc response of the intact
protein to the odorant. The observation that OR11H4 and
OR11H6 also respond to IVA is consistent with the notion
that OR proteins from the same subfamily tend to bind
similar odorants [29], and suggests that these three closely
related OR genes likely confer IVA perception in humans. In
view of that, speciﬁc hyperosmia for the sweaty odor of IVA
would likely occur only in people who carry the intact allele
of OR11H7P and hence possess enhanced detection capacity.
Nevertheless, we cannot exclude the possibility that the
observed association signal in this locus is a result of linkage
disequilibrium to other genetic variations such as copy
number polymorphisms [30], nonsynonymous SNPs in func-
tionally crucial positions [25], or genetic alterations in
regulatory sequences [31]. These could modify the expression
levels of one or more receptor genes and could consequently
underlie sensitivity differences towards the corresponding
ligands of the encoded proteins.
The IVA concentration (3 mM) that elicits response from
the three receptors from OR11H7Pi and its two other closely
related ORs is three orders of magnitude higher than the
threshold concentration detectable by individuals with
hyperosmia to this odorant. Such differences are consistent
with various observations in other studies. For example,
olfactory thresholds in mice range from 10
 9 to 10
 13 M
odorant concentration in the vapor phase [32,33], while the
concentrations of odorants required for the activation of ORs
in the isolated olfactory sensory neurons or in the hetero-
Figure 4. OR Responses to IVA
(A) Representative current traces from Xenopus oocytes expressing the
OR11H7Pi, OR52E4, OR11H4,o rOR11H6 receptor (see Materials and
Methods) challenged with 15-s applications of 3 mM IVA and 1 mM IBMX.
(B) Summary of the 4–12 recordings from oocytes expressing OR11H7Pi,
OR52E4, OR8A1, OR12D2, OR11H7P, OR11H4,o rOR11H6. Responses were
normalized to the 1 mM IBMX response in the same oocyte and are
presented as mean 6 standard error of the mean. Significant differences
from OR52E4, OR8A1, and OR12D2:* ,p , 0.05; **, p , 0.01. Significant
differences from OR11H7P:
, p , 0.05;
, p , 0.01.
doi:10.1371/journal.pbio.0050284.g004
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 5–10
 6 M in the aqueous
phase [34,35]. These discrepancies in sensitivity between in
vivo responses to odorants in the vapor phase and the
responses of dissociated olfactory sensory neurons to odor-
ants in the aqueous phase have been attributed to the
presence of olfactory mucus and the airﬂow in the nasal
cavity present in in vivo experiments [36] and absent in the in
vitro systems.
The human OR gene cluster 14@19.5 is in conserved
synteny, and within the same ‘‘cluster in conservation’’ [37] as
an OR cluster on mouse Chromosome 14. Notably, in mice,
speciﬁc olfactory threshold variation to IVA was shown to be
in genetic linkage to another OR locus (Iva1) on mouse
Chromosome 4 [18,38]. The entire OR cluster in this genomic
region is deleted in human [37,38]. Thus, it is possible that
two different OR gene loci harbor the genetic basis for IVA
sensitivity in the two mammals.
The results presented here imply a locus related to speciﬁc
hyperosmia. Similar enhanced speciﬁc olfactory sensitivities
have been reported only rarely, although support for a
genetic basis for general hyperosmia is found in mice
deﬁcient for Neu1 [39] and for the Kcna3 genes [40]. A case
of speciﬁc hyperosmia, for an unknown urinary metabolite of
asparagus, was also attributed to genetic polymorphism in
humans [15]; however, the underlying genetic locus has not
been identiﬁed.
This study also highlights the potential phenotypic impact
of often-neglected genomic loci—namely, pseudogenes. This
is because most eukaryotic mRNA molecules that contain
premature translation termination codons are either targeted
for rapid degradation by a nonsense-mediated decay mech-
anism [41] or likely produce truncated nonfunctional protein.
Thus, genomic loci annotated as pseudogenes are considered
as bearing no functional consequence on the phenotype.
Here we demonstrate that an OR annotated as a pseudogene
in the public databases may still have a functional allele in the
human population and consequently result in a discernible
phenotype.
Genetic polymorphisms in OR genes likely explain only
some of the remarkable threshold variation of human
individuals towards particular odorants. Other potential
contributing factors are intra-individual ﬂuctuation [6] and
environmental factors [14,15,42,43]. The observation of
signiﬁcant inter-odorant threshold correlation within indi-
viduals hints at the existence of a common mechanism that
affects an individual’s overall olfactory sensitivity. This is
consistent with the observations of Cain and Gent [6], who
postulated that such a mechanism may dominate the outcome
of odorant-speciﬁc threshold measurements. While this effect
could be related to differences in environmental exposures,
another appealing possibility is the involvement of other
genetic polymorphisms associated with variations in overall
olfactory perception. The observation that the association
signal between OR11H7P and IVA sensitivity did not change
when the general olfactory effect was introduced into the
statistical model implies that genetic polymorphisms in OR
genes may dictate sensitivity towards particular odorants
irrespective of other factors affecting overall olfactory
Figure 5. Excess of General Hyperosmia
(A) Histogram of average olfactory thresholds (adjusted for gender). The average threshold values for the four odorants were calculated for the raw data
(black bars) and for data generated by 1,000 permutations of the individual odorant thresholds (dotted bars). The significantly broader distribution of
the original data as compared to the permutated data (ANOVA, F ¼ 1.83, p ¼ 1.68 3 10
 10) indicates an excess of individuals with extreme threshold
values, particularly in the hypersensitivity end of the distribution.
(B) Combinations of odorant thresholds (adjusted for gender) for the four odorants. Shown are hyperosmia (lowest 10% of thresholds in the entire
sample, black), normosmia (middle 80%, gray), and hyposmia (highest 10%, white). Individuals with similar threshold patterns are clustered together.
For clarity, only 50 of the total of 123 normosmic individuals are shown. The probability of observing three individuals defined as generally hyperosmic
(i.e., having hyperosmia to all four odorants) in this cohort is computed as ;10
 12.
doi:10.1371/journal.pbio.0050284.g005
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extremes of human olfactory threshold distribution, could be
driven by both receptor-speciﬁc mechanisms and additional
elements common to all olfactory sensory neurons either in
the olfactory transduction pathway or in processes related to
olfactory cognition in the central nervous system. Further
research endeavors in this direction would help to unravel
additional pieces of the molecular basis of this fascinating
complex sensory mechanism.
Materials and Methods
Participant recruitment. This study was approved by the Institu-
tional Review Board (Helsinki Committee) of Meir Hospital in Kfar
Saba, Israel. Human participants (unrelated, randomly selected
individuals) were recruited in collaboration with the Israeli Blood
Bank (Tel Hashomer) within their blood-drawing sessions. Partic-
ipants included 197 females and 246 males, aged 18–48 y, originating
from three major Jewish ethnicities: 329 Ashkenazi, 61 Sephardic, and
53 Ashkenazi–Sephardic admixtures. Every participant signed an
informed consent form and ﬁlled in a detailed questionnaire in order
to exclude neurological impairments, nose injuries, and other
conditions with potential effect on human olfactory acuity. Age,
gender, ethnic origin, and smoking habits were also recorded.
Olfactory threshold measurements. Odorants, dissolved in light
white mineral oil (Sigma) at ﬁve 10-fold dilutions between 10
 2 M and
10
 6 M were presented in Snifﬁn’ Sticks kits [44]. These were replaced
every 3 mo to reduce contamination and odorant evaporation. The
odorants used were IAA (98%, Aldrich), IVA (99%, Sigma-Aldrich),
LCA (97%, Aldrich), and CIN ( 98.5%, Fluka). Detection thresholds
were determined using an ascending staircase three-way forced
choice procedure [10]. Odor presentation by cap removal was for ;3
s and presentation was ;2 cm in front of both nostrils. A single
failure led to the next higher concentration, and detection threshold
was the concentration showing four successive correct identiﬁcations,
assuring a low false positive rate (;0.01). To attain reduction of false
negative detection, the immediate subthreshold concentration was
retested and claimed threshold if successful. Inter-trial intervals were
.20 s, and participants were not given feedback on their perform-
ance during the test. All olfactory tests were conducted in a well-
ventilated, temperature-controlled, odorless room. A second olfac-
tory measurement was performed within 1–4 wk after the ﬁrst one for
82 randomly selected individuals to assess test–retest reproducibility.
SNP selection and genotyping. Genomic DNA was extracted from
10 ml of peripheral blood using a DNA Isolation Kit for Mammalian
Blood (Roche). The DNA concentrations were measured using the
Genius spectrophotometer at 260 nm (Tecan) and subsequently
normalized to 2.5 ng/ll. Aliquots of 2 ll were distributed in 384
microtiter plates by the Biomek 2000 laboratory automation work-
station (Beckman).
We employed a candidate gene/SNP approach aimed at detecting
the causative genetic polymorphism of human odor-speciﬁc thresh-
old variation. Therefore, the underlying SNPs of 52 nonsense and
missense SPGs [24,25], SNPs with obvious potential causative effect,
were considered for the genotyping effort of this study. SNP
genotypes were assessed by the matrix-assisted laser desorption/
ionization–time of ﬂight (MALDI-TOF) mass spectrometry technol-
ogy of Sequenom [45]. This procedure involved multiplexes of 10–24
SNP reactions, automatically designed by the SpectroDESIGNER
algorithm (Sequenom) and validated for speciﬁc genomic ampliﬁca-
tion using UCSC In-Silico PCR (http://genome.ucsc.edu/cgi-bin/
hgPcr). SNP genotyping was performed twice, and inconsistencies
were removed from further analyses. Overall, high genotyping
efﬁciency (98% 6 3%) was achieved for the 52 polymorphic loci.
SNP allele frequencies were tested for deviations from Hardy–
Weinberg equilibrium. This test may indicate SNPs with errors in
their genotyping process. Consequently, ﬁve SNPs were removed
from further analysis (Table S2). Four additional SNPs with low
minor allele frequency (,0.05; Table S2) were also not included in
our association analyses because of the lack of statistical power to
detect association even if existed. Thus, a total of 43 polymorphic loci
remained for the genotype–phenotype association analysis.
OR functional expression. In vitro functional expressions of ORs
were carried out as previously described [27]. OR coding regions were
ampliﬁed from human genomic DNA by PCR using speciﬁc primers
(BD Biosciences/Clontech), subcloned into a pCI vector (Promega)
containing the 20-amino-acid N-terminal sequence of human
rhodopsin (to aid in functional expression in this system), and
conﬁrmed by sequencing. The disrupting stop codon (TAG) (nucleo-
tide thymine at position 679) of OR11H7P was corrected to a CAG
codon for glutamine (as in the intact allele) using the QuickChange II
site-directed mutagenesis kit (Stratagene), and veriﬁed by sequencing.
Each Xenopus laevis oocyte was injected with 25 ng of the receptor
cRNA, together with 10 ng of human GNAL cRNA and 1 ng of human
CFTR cRNA. Currents, in response to IVA application, were
measured under two-electrode voltage clamp. Results are reported
as the ratio of current amplitudes elicited by the odorant and the
phosphodiesterase inhibitor IBMX. Statistical analysis of functional
data was done using one-way ANOVA, followed by Dunnett’s post-
test. X. laevis frogs were purchased from Nasco. The care and use of X.
laevis frogs was approved by the University of Miami Animal Research
Committee. Detailed methods for the preparation of oocytes have
been previously described [27].
Statistical analyses. Analysis of variance (ANOVA) was used to test
the potential effect of gender, ethnic origin (Ashkenazi Jewish,
Sephardic Jewish, Ashkenazi–Sephardic Jewish admixture, or other),
and smoking habits (.20 cigarettes/day, 11–20 cigarettes/day, 1–10
cigarettes/day, or nonsmoking) on odorant thresholds. Pearson
correlation was used to assess the relationship between olfactory
threshold and age of the participants. We used ANOVA to test for
genotype–phenotype associations by comparing the average olfactory
threshold of individuals with different SPG genotypes. For that, we
assumed a recessive mode of inheritance (i.e., combining the
heterozygous and homozygous intact genotypes) and adding ‘‘gen-
der’’ and ‘‘gender by genotype’’ as other covariates. The recessive
hypothesis was explicitly conﬁrmed (F ¼1.43, p ¼0.24) by calculating
the reduced ﬁt between a 2-df test (additive) and 1-df test (recessive)
using a likelihood ratio test. The interaction term ‘‘gender by
genotype’’ did not have a signiﬁcant effect (F ¼ 0.17, p ¼ 0.68 for
‘‘OR11H7P3gender’’), therefore justifying the pooling of sexes in the
analyses. The statistical analyses were carried out using the statistical
toolbox of Matlab.
Supporting Information
Figure S1. Test–Retest Reproducibility
The ﬁrst and second thresholds (in –log10 molar concentrations) of 82
individuals are plotted for the four odorants. Circle areas are
proportional to the number of participants with similar scores. Test–
retest reproducibility is demonstrated by the high correlation
coefﬁcient scores.
Found at doi:10.1371/journal.pbio.0050284.sg001 (23 KB PDF).
Figure S2. Inter-Odorant Threshold Correlations
The adjusted thresholds (due to the gender effect) of individuals are
plotted for all possible odorant pairs. Modest correlation coefﬁcients
(0.12   R   0.5, p , 0.01) in the different panels imply that a
common denominator has a moderate effect on olfactory sensitivity
towards all odorants.
Found at doi:10.1371/journal.pbio.0050284.sg002 (43 KB PDF).
Table S1. Olfactory Threshold Confounding Factors
ANOVA (F) statistics and their corresponding p-values are given for
the effect of gender, smoking, and ethnic origin on olfactory
threshold variation for the different odorants. Pearson correlation
coefﬁcients (R) and their p-values indicate the effect of age on
odorant thresholds.
Found at doi:10.1371/journal.pbio.0050284.st001 (35 KB DOC).
Table S2. OR SPG Information
OR SPGs are ordered according to their genomic location. The four
genes with minor allele frequency below 0.05 (marked with a number
sign) and the ﬁve genes with genotypes deviating signiﬁcantly from
Hardy–Weinberg (p , 0.05, Chi-square test; marked with an asterisk)
were not included in the genotype–phenotype analyses.
Found at doi:10.1371/journal.pbio.0050284.st002 (128 KB DOC).
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